Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2018 Feb 21 Epub: 2018 Feb 21 Authors Cheng W , Lu J , Lin W , Wei X , Li H , Zhao X , Jiang A , Yuan J , |
|
|
Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2018 Feb 21 Epub: 2018 Feb 21 Authors Cheng W , Lu J , Lin W , Wei X , Li H , Zhao X , Jiang A , Yuan J , |
|
|
Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2018 Feb 21 Epub: 2018 Feb 21 Authors Cheng W , Lu J , Lin W , Wei X , Li H , Zhao X , Jiang A , Yuan J , |
|
|
Effects of a galacto-oligosaccharide-rich diet on fecal microbiota and metabolite profiles in mice. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2018 Feb 21 Epub: 2018 Feb 21 Authors Cheng W , Lu J , Lin W , Wei X , Li H , Zhao X , Jiang A , Yuan J , |
|
|
High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 7 Issue 2 Pages: 247-64 Pub: 2016 Epub: 2016 Feb 3 Authors Monteagudo-Mera A , Arthur JC , Jobin C , Keku T , Bruno-Barcena JM , Azcarate-Peril MA , |
|
|
High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 7 Issue 2 Pages: 247-64 Pub: 2016 Epub: 2016 Feb 3 Authors Monteagudo-Mera A , Arthur JC , Jobin C , Keku T , Bruno-Barcena JM , Azcarate-Peril MA , |
|
|
High purity galacto-oligosaccharides enhance specific Bifidobacterium species and their metabolic activity in the mouse gut microbiome. ✅
Go to Publication ✅
Beneficial microbes (Benef Microbes ) Vol: 7 Issue 2 Pages: 247-64 Pub: 2016 Epub: 2016 Feb 3 Authors Monteagudo-Mera A , Arthur JC , Jobin C , Keku T , Bruno-Barcena JM , Azcarate-Peril MA , |
|
|
Modifications in gut microbiota and fermentation metabolites in the hindgut of rats after the consumption of galactooligosaccharide glycated with a fish peptide. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 9 Issue 5 Pages: 2853-2864 Pub: 2018 May 1 Epub: 2018 Apr 27 Authors Jin W , Han K , Dong S , Yang Y , Mao Z , Su M , Zeng M , |
|
|
Fructooligosaccharide (FOS) and Galactooligosaccharide (GOS) Increase Bifidobacterium but Reduce Butyrate Producing Bacteria with Adverse Glycemic Metabolism in healthy young population. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 7 Issue 1 Pages: 11789 Pub: 2017 Sep 18 Epub: 2017 Sep 18 Authors Liu F , Li P , Chen M , Luo Y , Prabhakar M , Zheng H , He Y , Qi Q , Long H , Zhang Y , Sheng H , Zhou H , |
|
|
Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. ✅
Go to Publication ✅
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 114 Issue 3 Pages: E367-E375 Pub: 2017 Jan 17 Epub: 2017 Jan 3 Authors Azcarate-Peril MA , Ritter AJ , Savaiano D , Monteagudo-Mera A , Anderson C , Magness ST , Klaenhammer TR , |
|
|
Impact of short-chain galactooligosaccharides on the gut microbiome of lactose-intolerant individuals. ✅
Go to Publication ✅
Proceedings of the National Academy of Sciences of the United States of America (Proc Natl Acad Sci U S A ) Vol: 114 Issue 3 Pages: E367-E375 Pub: 2017 Jan 17 Epub: 2017 Jan 3 Authors Azcarate-Peril MA , Ritter AJ , Savaiano D , Monteagudo-Mera A , Anderson C , Magness ST , Klaenhammer TR , |
|
|
Galactooligosaccharides ameliorate dietary advanced glycation end product-induced intestinal barrier damage in C57BL/6 mice by modulation of the intestinal microbiome. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: Issue Pages: Pub: 2022 Dec 20 Epub: 2022 Dec 20 Authors Nie C , Xie X , Liu H , Yuan X , Ma Q , Tu A , Zhang M , Chen Z , Li J , |
|
|
Dietary Galactooligosaccharides Supplementation as a Gut Microbiota-Regulating Approach to Lower Early Life Arsenic Exposure. ✅
Go to Publication ✅
Environmental science & technology (Environ Sci Technol ) Vol: Issue Pages: Pub: 2023 Nov 9 Epub: 2023 Nov 9 Authors Zhang YS , Juhasz AL , Xi JF , Ma LQ , Zhou D , Li HB , |
|
|
Microbiota-Focused Dietary Approaches to Support Health: A Systematic Review. ✅
Go to Publication ✅
The Journal of nutrition (J Nutr ) Vol: 155 Issue 2 Pages: 381-401 Pub: 2025 Feb Epub: 2024 Oct 31 Authors Hindle VK , Veasley NM , Holscher HD , |
|
|
Maternal intervention with a combination of galacto-oligosaccharides and hyocholic acids during late gestation and lactation increased the reproductive performance, colostrum composition, antioxidant and altered intestinal microflora in sows. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 15 Issue Pages: 1367877 Pub: 2024 Epub: 2024 Jun 12 Authors Yu J , Wang J , Cao C , Gong J , Cao J , Yin J , Wu S , Huang P , Tan B , Fan Z , |
|
|
Galacto-oligosaccharides alleviate experimental lactose intolerance associated with gut microbiota in mice. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 16 Issue Pages: 1530156 Pub: 2025 Epub: 2025 Mar 25 Authors Li Q , Wang X , Guo S , Wang T , Cao H , Cao Y , Dong B , |
|
|
Biological activity of galacto-oligosaccharides: A review. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 13 Issue Pages: 993052 Pub: 2022 Epub: 2022 Sep 6 Authors Mei Z , Yuan J , Li D , |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]
